Aamer Sandoo

Short-term effects of rituximab on flow-mediated dilatation may be mediated by intravenous glucocorticoids: comment on the article by Gonzalez-Juanatey et al.

Atherosclerosis in rheumatoid arthritis versus diabetes: a comparative study.

Mean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNF-α therapy.

Vascular function and inflammation in rheumatoid arthritis: the role of physical activity.

The endothelium and its role in regulating vascular tone.

The association between microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional study.

Disease activity and low physical activity associate with number of hospital admissions and length of hospitalisation in patients with rheumatoid arthritis.

Vascular function and morphology in rheumatoid arthritis: a systematic review.

The role of inflammation and cardiovascular disease risk on microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional and longitudinal study.

Clinical remission following treatment with tumour necrosis factor-alpha antagonists is not accompanied by changes in asymmetric dimethylarginine in patients with rheumatoid arthritis.

Anti-TNFα therapy transiently improves high density lipoprotein cholesterol levels and microvascular endothelial function in patients with rheumatoid arthritis: a pilot study.

The role of inflammation, the autonomic nervous system and classical cardiovascular disease risk factors on subendocardial viability ratio in patients with RA: a cross-sectional and longitudinal study.

Asymmetric dimethylarginine as a surrogate marker of endothelial dysfunction and cardiovascular risk in patients with systemic rheumatic diseases.

Individualised exercise improves endothelial function in patients with rheumatoid arthritis.

The association between functional and morphological assessments of endothelial function in patients with rheumatoid arthritis: a cross-sectional study.

Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: an association driven by high inflammatory burden.

Classical cardiovascular disease risk factors associate with vascular function and morphology in rheumatoid arthritis: a six-year prospective study.

Asymmetric dimethylarginine is not associated with subendocardial viability ratio in Rheumatoid Arthritis.

Endothelial dysfunction as a determinant of trastuzumab-mediated cardiotoxicity in patients with breast cancer.

The relationship between cardiovascular disease risk prediction scores and vascular function and morphology in rheumatoid arthritis.

Cumulative inflammation associates with asymmetric dimethylarginine in rheumatoid arthritis: a 6 year follow-up study.

Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis.